137 related articles for article (PubMed ID: 25898709)
1. Two cases of cytarabine syndrome successfully resolved by desensitization.
Lim KH; Kim JY; Kang MG; Park HK; Kang HR
J Investig Allergol Clin Immunol; 2015; 25(1):80-2. PubMed ID: 25898709
[No Abstract] [Full Text] [Related]
2. [A phase II study with high-dose cytarabine (NS-075) in adult patients with relapsed and refractory acute leukemia].
Miyawaki S; Mizoguchi H; Tomonaga M; Kanamaru A; Tsukagoshi S; Nakamura T; Ohashi Y; Yoshida S; Ohno R
Gan To Kagaku Ryoho; 1998 Dec; 25(14):2229-42. PubMed ID: 9881080
[TBL] [Abstract][Full Text] [Related]
3. [Effectiveness of remission induction with high-dose cytarabine for relapsed or refractory pediatric acute leukemia].
Horikoshi Y; Kobayashi R; Endo M; Watanabe A; Kikuta A; Koike K; Hanada R; Hosoya R; Ohara A; Ikuta K; Goto H; Asami K; Sugita K; Horibe K; Tsurusawa M; Hori T; Hara J; Nishimura S; Nagatoshi Y; Mugishima H; Ohta S; Adachi S; Tsukimoto I
Rinsho Ketsueki; 2010 Feb; 51(2):104-13. PubMed ID: 20379101
[TBL] [Abstract][Full Text] [Related]
4. High-dose cytarabine-based therapy in adults with acute lymphoblastic leukemia.
Feldman EJ
Leuk Res; 2000 Mar; 24(3):189-91. PubMed ID: 10739000
[No Abstract] [Full Text] [Related]
5. Cytarabine dose for acute myeloid leukemia.
Löwenberg B; Pabst T; Vellenga E; van Putten W; Schouten HC; Graux C; Ferrant A; Sonneveld P; Biemond BJ; Gratwohl A; de Greef GE; Verdonck LF; Schaafsma MR; Gregor M; Theobald M; Schanz U; Maertens J; Ossenkoppele GJ;
N Engl J Med; 2011 Mar; 364(11):1027-36. PubMed ID: 21410371
[TBL] [Abstract][Full Text] [Related]
6. Cytarabine dose for acute myeloid leukemia.
Mori J; Tsubokura M; Kami M
N Engl J Med; 2011 Jun; 364(22):2166-7; author reply 2168-9. PubMed ID: 21631342
[No Abstract] [Full Text] [Related]
7. Tumor Lysis Syndrome: An Unreported Complication of Intrathecal Ara-C.
Simangan LR; Kline RM
J Pediatr Hematol Oncol; 2015 Apr; 37(3):227-9. PubMed ID: 24942026
[TBL] [Abstract][Full Text] [Related]
8. [Significance of C-reaction protein for differential diagnosis of fever after chemotherapy on children with acute lymphoblastic leukemia].
Fang CQ; Tang YM; Li HF; Song H; Shi SW; Yang SL; Xu WQ
Zhonghua Er Ke Za Zhi; 2004 Jul; 42(7):536-7. PubMed ID: 15324576
[No Abstract] [Full Text] [Related]
9. Does high-dose cytarabine cause cumulative toxicity in patients undergoing consolidation therapy for acute myeloid leukemia?
Wiernik A; Sperr WR; Weisdorf D; Valent P; Ustun C
Am J Hematol; 2013 Jun; 88(6):533-4. PubMed ID: 23526441
[No Abstract] [Full Text] [Related]
10. Cytarabine ears - A side effect of cytarabine therapy.
Doval D; Kumar Sharma S; Kumar M; Khandelwal V; Choudhary D
J Oncol Pharm Pract; 2020 Mar; 26(2):471-473. PubMed ID: 31117913
[TBL] [Abstract][Full Text] [Related]
11. Cytarabine syndrome despite corticosteroid premedication in an adult undergoing induction treatment for acute myelogenous leukemia.
Jirasek MA; Herrington JD
J Oncol Pharm Pract; 2016 Dec; 22(6):795-800. PubMed ID: 26419692
[TBL] [Abstract][Full Text] [Related]
12. A successful desensitization in an adult patient with ARA-C infusion reaction.
Akgul Balaban Y; Inan MI; Selcuk A; Kartal O; Zengin H; Bulduk T
J Oncol Pharm Pract; 2024 Jun; 30(4):780-782. PubMed ID: 38545702
[TBL] [Abstract][Full Text] [Related]
13. Myelopathy due to intrathecal chemotherapy: magnetic resonance imaging findings.
Counsel P; Khangure M
Clin Radiol; 2007 Feb; 62(2):172-6. PubMed ID: 17207701
[No Abstract] [Full Text] [Related]
14. Neuroophthalmological side effects following intrathecal administration of liposomal cytarabine for central nervous system prophylaxis in three adolescents with acute myeloid leukaemia.
Sommer C; Lackner H; Benesch M; Sovinz P; Schwinger W; Moser A; Bergloeff J; Gruber A; Urban C
Ann Hematol; 2008 Nov; 87(11):887-90. PubMed ID: 18575860
[TBL] [Abstract][Full Text] [Related]
15. Neurological complications after intrathecal liposomal cytarabine application in patients after allogeneic haematopoietic stem cell transplantation.
Hilgendorf I; Wolff D; Junghanss C; Kahl C; Leithaeuser M; Steiner B; Casper J; Freund M
Ann Hematol; 2008 Dec; 87(12):1009-12. PubMed ID: 18704421
[TBL] [Abstract][Full Text] [Related]
16. Anterior uveitis associated with high-dose cytosine arabinoside.
Fintelmann RE; Qian Y; Skalet A; Jeng BH
Ocul Immunol Inflamm; 2010 Dec; 18(6):485-7. PubMed ID: 20887203
[TBL] [Abstract][Full Text] [Related]
17. "Flushing out" cytosine arabinoside from CSF to reverse neurotoxicity.
Bleyer A
J Pediatr Hematol Oncol; 2007 Apr; 29(4):274. PubMed ID: 17414574
[No Abstract] [Full Text] [Related]
18. Neutropenia-associated outcomes in adults with acute myeloid leukemia receiving cytarabine consolidation chemotherapy with or without granulocyte colony-stimulating factor.
Bradley AM; Deal AM; Buie LW; van Deventer H
Pharmacotherapy; 2012 Dec; 32(12):1070-7. PubMed ID: 23208834
[TBL] [Abstract][Full Text] [Related]
19. Aseptic meningitis in a child after systemic treatment with high dose cytarabine.
Pease CL; Horton TM; McClain KL; Kaplan SL
Pediatr Infect Dis J; 2001 Jan; 20(1):87-9. PubMed ID: 11176579
[TBL] [Abstract][Full Text] [Related]
20. Severe anterior uveitis as a complication of high-dose cytosine-arabinoside.
Moberg J; Carlsson M; Holm C; Koranyi G
Acta Ophthalmol; 2009 Nov; 87(8):922-3. PubMed ID: 19799589
[No Abstract] [Full Text] [Related]
[Next] [New Search]
